These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens. Serruto D; Adu-Bobie J; Capecchi B; Rappuoli R; Pizza M; Masignani V J Biotechnol; 2004 Sep; 113(1-3):15-32. PubMed ID: 15380644 [TBL] [Abstract][Full Text] [Related]
6. Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens. Meinke A; Henics T; Hanner M; Minh DB; Nagy E Vaccine; 2005 Mar; 23(17-18):2035-41. PubMed ID: 15755567 [TBL] [Abstract][Full Text] [Related]
7. [Antigenome technology: rapid and comprehensive identification and validation of antigens as putative components in vaccines against bacterial pathogens]. Henics T; Nagy E Orv Hetil; 2005 Oct; 146(43):2209-14. PubMed ID: 16323567 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatics: how it is being used to identify bacterial vaccine candidates. Zagursky RJ; Olmsted SB; Russell DP; Wooters JL Expert Rev Vaccines; 2003 Jun; 2(3):417-36. PubMed ID: 12903807 [TBL] [Abstract][Full Text] [Related]
10. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. Mora M; Donati C; Medini D; Covacci A; Rappuoli R Curr Opin Microbiol; 2006 Oct; 9(5):532-6. PubMed ID: 16890009 [TBL] [Abstract][Full Text] [Related]
11. Developing vaccines in the era of genomics: a decade of reverse vaccinology. Seib KL; Zhao X; Rappuoli R Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():109-16. PubMed ID: 22882709 [TBL] [Abstract][Full Text] [Related]
15. The impact of genomics on vaccine design. Scarselli M; Giuliani MM; Adu-Bobie J; Pizza M; Rappuoli R Trends Biotechnol; 2005 Feb; 23(2):84-91. PubMed ID: 15661345 [TBL] [Abstract][Full Text] [Related]
16. Application of genomics in bacterial vaccine discovery: a decade in review. Zagursky RJ; Anderson AS Curr Opin Pharmacol; 2008 Oct; 8(5):632-8. PubMed ID: 18625342 [TBL] [Abstract][Full Text] [Related]
17. Reverse vaccinology and genomics. Rappuoli R; Covacci A Science; 2003 Oct; 302(5645):602. PubMed ID: 14576423 [TBL] [Abstract][Full Text] [Related]
18. Genome-based vaccine development: a short cut for the future. Moriel DG; Scarselli M; Serino L; Mora M; Rappuoli R; Masignani V Hum Vaccin; 2008; 4(3):184-8. PubMed ID: 20686357 [TBL] [Abstract][Full Text] [Related]
19. Identification of broad cross-protective immunogens using heterogeneous antiserum-based immunoproteomic approach. Li H; Xiong XP; Peng B; Xu CX; Ye MZ; Yang TC; Wang SY; Peng XX J Proteome Res; 2009 Sep; 8(9):4342-9. PubMed ID: 19640004 [TBL] [Abstract][Full Text] [Related]
20. Bacterial infectious disease control by vaccine development. Curtiss R J Clin Invest; 2002 Oct; 110(8):1061-6. PubMed ID: 12393839 [No Abstract] [Full Text] [Related] [Next] [New Search]